Skip to main content

Advertisement

Log in

National immunization programmes

Nationale Impfprogramme

  • Leitthema
  • Published:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz Aims and scope

Abstract

Immunization represents one of the most cost-effective means to improve the health and well-being of populations and contribute to sustainable development. Since the inception of the Expanded Programme on Immunization (EPI) in 1974, considerable gains have been made in improving access to vaccination in all countries. However, the full potential of vaccination is yet to be tapped.

Health system weaknesses have prevented universal access to vaccination and are a limitation for sustainable use of the increasing array of new vaccines. Fortunately, solutions exist and opportunities are available to strengthen immunization systems and to implement strategies to achieve the vision of universal access to vaccines. National immunization programmes are responsible for the management of immunization at the country level and cover a range of functions from establishing evidence-based policies to financing and procurement of vaccines, vaccine management and logistics, delivery of vaccination services and collection, as well as analysis and use of immunization data. Well-functioning immunization programmes that deliver high-quality services using tailored strategies to meet the needs of different population groups can reap the health benefits of high and equitable coverage with vaccines.

Zusammenfassung

Impfungen gehören zu den kosteneffektivsten Maßnahmen zur Verbesserung der öffentlichen Gesundheit und tragen wesentlich zur nachhaltigen Entwicklung bei. Seit der Einführung des „erweiterten Impfprogramms“ (Expanded Programme on Immunization [EPI]) im Jahr 1974 wurden in allen Ländern weltweit erhebliche Verbesserungen im Zugang zu Impfungen erzielt. Das Potenzial, das Impfungen bieten, ist jedoch weiterhin nicht voll ausgeschöpft. Schwächen in Gesundheitssystemen verhindern den universellen Zugang zu Impfungen und die Einführung neuer Impfstoffe, die in zunehmender Anzahl zur Verfügung stehen. Doch es gibt vielfältige Möglichkeiten, nationale Impfprogramme zu stärken und globale Strategien für den universellen Zugang zu Impfstoffen in den Ländern umzusetzen. Nationale Impfprogramme decken eine Reihe von Funktionen ab. Zu diesen gehören die Erstellung evidenzbasierter Impfempfehlungen, die Finanzierung und Beschaffung von Impfstoffen, die Impfstofflogistik und die Organisation von Impfangeboten, darüber hinaus auch die Erhebung, Analyse und adäquate Nutzung von Daten. Gut funktionierende und qualitativ hochwertige Impfprogramme, die mit maßgeschneiderten Strategien auf die Bedürfnisse verschiedener Bevölkerungsgruppen eingehen, können durch das Erreichen eines ausreichend hohen und gerecht verteilten Impfschutzes zur nachhaltigen Verbesserung der Gesundheit in der Bevölkerung beitragen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Miller MA, Hinman AR (2013) Economic analysis of vaccine policies. In: Plotkin W, Orenstein A, Offit PA (eds) Vaccines. Elsevier Saunders, Philadelphia, pp 1413–1426

    Chapter  Google Scholar 

  2. Bloom DE (2011) The value of vaccination. Adv Exp Med Biol 697:1–8

    Article  Google Scholar 

  3. Ozawa S et al (2016) Return on investment from childhood immunization in low- and middle-income countries, 2011–20. Health Aff (Millwood) 35(2):199–207

    Article  Google Scholar 

  4. Duclos P et al (2009) Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights 9(Suppl 1):S2

    Article  Google Scholar 

  5. Okwo-Bele JM, Cherian T (2011) The expanded programme on immunization: a lasting legacy of smallpox eradication. Vaccine 29(Suppl 4):D74–D79

    Article  Google Scholar 

  6. Gavi (2019) Vaccine investment strategy. https://www.gavi.org/about/strategy/vaccine-investment-strategy/. Accessed 31 May 2019

  7. Flasche S et al (2014) Early indication for a reduced burden of radiologically confirmed pneumonia in children following the introduction of routine vaccination against Haemophilus influenzae type b in Nha Trang, Vietnam. Vaccine 32(51):6963–6970

    Article  Google Scholar 

  8. Moxon ER et al (2011) A call to action for the new decade of vaccines. Lancet 378(9788):298–302

    Article  Google Scholar 

  9. World Health Organization (2013) Global vaccine action plan 2011–2020. http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/index.html. Accessed 25/11/2019

  10. World Health Organization (2016) 2016 midterm review of the global vaccine action plan. WHO, Geneva

    Google Scholar 

  11. World Health Organization (2019) Immunization coverage. https://www.who.int/news-room/fact-sheets/detail/immunization-coverage. Accessed 18 July 2019

  12. World Health Organization (2018) Assessment report of the global vaccine action plan 2018. WHO, Geneva

    Google Scholar 

  13. World Health Organization (2019) SAGE working mechanisms and working groups. https://www.who.int/immunization/sage/working_mechanisms/en/. Accessed 1 June 2019

  14. Guyatt GH et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924–926

    Article  Google Scholar 

  15. World Health Organization (2014) Regional technical advisory groups on immunization. https://www.who.int/immunization/sage/regional/en/. Accessed 30 May 2019

  16. World Health Organization (2018) Global vaccine action plan monitoring, evaluation and accountability. Secretariat annual report 2018. https://www.who.int/immunization/global_vaccine_action_plan/web_gvap_secretariat_report_2018.pdf?ua=1. Accessed 25/11/2019

  17. NITAG Resource Centre (2019) Homepage. http://www.nitag-resource.org/. Accessed 30 May 2019

  18. WHO, UNICEF (2014) Guidelines for comprehensive multi-year planning for immunization

    Google Scholar 

  19. Gandhi G et al (2013) Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011–2020. Vaccine 31(Suppl 2):B137–B148

    Article  Google Scholar 

  20. World Health Organization (2006) The world health report 2006: working together for health. WHO, Geneva

    Book  Google Scholar 

  21. Hu Y et al (2014) Public health workers and vaccination coverage in Eastern China: a health economic analysis. Int J Environ Res Public Health 11(5):5555–5566

    Article  Google Scholar 

  22. Kruk ME et al (2009) Are doctors and nurses associated with coverage of essential health services in developing countries? A cross-sectional study. Hum Resour Health 7:27

    Article  Google Scholar 

  23. Mitchell AD et al (2008) Health worker densities and immunization coverage in Turkey: a panel data analysis. Hum Resour Health 6:29

    Article  Google Scholar 

  24. World Health Organization (2018) Standard competencies framework for the immunization workforce. https://www.who.int/immunization/programmes_systems/workforce/standard_competencies_framework/en/. Accessed 31 May 2019

  25. World Health Organization (2019) Immunization training resources. https://www.who.int/immunization/documents/training/en/. Accessed 31 May 2019

  26. Greco M (2001) Key drivers behind the development of global vaccine market. Vaccine 19(13–14):1606–1610

    Article  CAS  Google Scholar 

  27. Maggon K (2009) Industrial R&D paradigm shift to vaccines. Biotechnol J 4(4):458–461

    Article  CAS  Google Scholar 

  28. Vandersmissen W (2001) WHO expectation and industry goals. Vaccine 19(13–14):1611–1615

    Article  CAS  Google Scholar 

  29. Gupta SS et al (2013) Vaccine development and deployment: opportunities and challenges in India. Vaccine 31(Suppl 2):B43–B53

    Article  Google Scholar 

  30. Milstien JB, Kaddar M (2010) The role of emerging manufacturers in access to innovative vaccines of public health importance. Vaccine 28(9):2115–2121

    Article  Google Scholar 

  31. Pagliusi S et al (2013) Developing countries vaccine manufacturers network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012. Vaccine 31(31):3111–3115

    Article  Google Scholar 

  32. World Health Organization (2019) Global vaccine action plan: monitoring, evaluation and accountability secretariat annual report 2018. https://www.who.int/immunization/global_vaccine_action_plan/web_gvap_secretariat_report_2018.pdf?ua=1. Accessed 15 Oct 2019

  33. Makinen M et al (2012) New vaccine adoption in lower-middle-income countries. Health Policy Plan 27:ii39–ii49

    Article  Google Scholar 

  34. World Health Organization (2019) MI4A: market information for access to vaccines. https://www.who.int/immunization/programmes_systems/procurement/v3p/platform/en/. Accessed 31 May 2019

  35. World Health Organization (2018) Effective vaccine management (EVM) initiative. https://www.who.int/immunization/programmes_systems/supply_chain/evm/en/. Accessed 1 June 2019

  36. World Health Organization (2018) Effective vaccine management (EVM) global data analysis 2009–2016. https://www.who.int/immunization/programmes_systems/supply_chain/EVM-Global-Data-Analysis-2010-2016-EN.pdf?ua=1. Accessed 31 May 2019

  37. McCarney S et al (2013) Using solar-powered refrigeration for vaccine storage where other sources of reliable electricity are inadequate or costly. Vaccine 31(51):6050–6057

    Article  Google Scholar 

  38. Lloyd J et al (2015) Optimizing energy for a ‘green’ vaccine supply chain. Vaccine 33(7):908–913

    Article  Google Scholar 

  39. World Health Organization (2017) A guide for conducting an expanded programme on immunization (EPI) review. WHO, Geneva

    Google Scholar 

  40. World Health Organization (2010) New vaccine post-introduction evaluation (PIE) tool. WHO, Geneva

    Google Scholar 

  41. Cutts FT, Izurieta HS, Rhoda DA (2013) Measuring coverage in MNCH: design, implementation, and interpretation challenges associated with tracking vaccination coverage using household surveys. PLoS Med 10(5):e1001404

    Article  Google Scholar 

  42. Dietz V et al (2004) Assessing and monitoring vaccination coverage levels: lessons from the Americas. Rev Panam Salud Publica 16(6):432–442

    Article  Google Scholar 

  43. Danovaro-Holliday MC et al (2014) Electronic immunization registries in Latin America: progress and lessons learned. Rev Panam Salud Publica 35(5–6):453–457

    PubMed  Google Scholar 

  44. Luhm KR, Cardoso MR, Waldman EA (2011) Vaccination coverage among children under two years of age based on electronic immunization registry in Southern Brazil. Rev Saude Publica 45(1):90–98

    Article  Google Scholar 

  45. Crowcroft NS (2009) Action on immunisation: no data, no action. Arch Dis Child 94(11):829–830

    Article  CAS  Google Scholar 

  46. World Health Organization (2018) World Health Organization vaccination coverage cluster surveys: reference manual. https://www.who.int/immunization/documents/who_ivb_18.09/en/. Accessed 1 June 2019

  47. UNICEF (2015) Multiple indicator cluster surveys (MICS). http://mics.unicef.org/. Accessed 20 May 2015

  48. The DHS Program (2019) Demographic and health surveys. https://www.dhsprogram.com/. Accessed 1 June 2019

  49. World Health Organization (2018) Vaccine preventable diseases surveillance standards. https://www.who.int/immunization/monitoring_surveillance/burden/vpd/standards/en/. Accessed 1 June 2019

  50. World Health Organization (2012) Global vaccine safety blueprint. https://apps.who.int/iris/bitstream/handle/10665/70919/WHO_IVB_12.07_eng.pdf;jsessionid=D59F5DC3F9FDD553E6D62CAB4B849A24?sequence=1. Accessed 15 Oct 2019

Download references

Acknowledgements

The authors gratefully acknowledge access to unpublished data and graphics provided by the department of Immunization, Vaccines and Biologicals, World Health Organization for preparing this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carsten Mantel.

Ethics declarations

Conflict of interest

T. Cherian and C. Mantel declare that they have no competing interests.

For this article no studies with human participants or animals were performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cherian, T., Mantel, C. National immunization programmes. Bundesgesundheitsbl 63, 16–24 (2020). https://doi.org/10.1007/s00103-019-03062-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00103-019-03062-1

Keywords

Schlüsselwörter

Navigation